Hyperfine (HYPR) EBITDA Margin (QoQ) (2021 - 2026)
Hyperfine (HYPR) EBITDA Margin (QoQ) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn |
| 10 | Hyperfine | 88.36 Mn | 43.60 Mn | 1.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 234.00 |
| Mar 31, 2026 | -7,440.00 |
| Dec 31, 2025 | 11,466.00 |
| Sep 30, 2025 | 9,637.00 |
| Jun 30, 2025 | 15,426.00 |
| Mar 31, 2025 | -4,635.00 |
| Dec 31, 2024 | -16,288.00 |
| Sep 30, 2024 | -223.00 |
| Jun 30, 2024 | 2,451.00 |
| Mar 31, 2024 | 10,973.00 |
| Dec 31, 2023 | 7,173.00 |
| Sep 30, 2023 | -15,886.00 |
| Jun 30, 2023 | 14,887.00 |
| Mar 31, 2023 | 46,241.00 |
| Dec 31, 2022 | -39,142.00 |
| Sep 30, 2022 | 94,718.00 |
| Jun 30, 2022 | 6,243.00 |
| Mar 31, 2022 | 440,798.00 |
| Dec 31, 2021 | -156,547.00 |
| Sep 30, 2021 | -34,349.00 |